Joshua Pinto's most recent trade in Neumora Therapeutics Inc. was a trade of 1,200,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2026 | 1,200,000 | 1,200,000 | - | - | Stock Option (Right to Buy) | |
| Metsera Inc | Joshua Pinto | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Nov 2025 | 148,953 | 0 | - | - | Stock Option (right to buy) | |
| Metsera Inc | Joshua Pinto | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Nov 2025 | 16,125 | 0 | - | - | Stock Option (right to buy) | |
| Metsera Inc | Joshua Pinto | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Nov 2025 | 2,688 | 0 | - | - | Common Stock | |
| Metsera Inc | Joshua Pinto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2025 | 2,688 | 2,688 | - | - | Restricted Stock Unit | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 3,000,000 | 3,000,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 3,000,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 720,084 | 720,084 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 720,084 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 270,828 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 270,828 | 270,828 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 223,034 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 223,034 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 223,034 | 223,034 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 223,034 | 223,034 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 170,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 127,448 | 127,448 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 127,448 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Gift of securities by or to the insider at price $ 0.00 per share. | 21 May 2025 | 13,202 | 63,750 | - | 0 | Common Stock | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Gift of securities by or to the insider at price $ 0.00 per share. | 21 May 2025 | 13,202 | 152,167 | - | 0 | Common Stock | |
| Metsera Inc | Joshua Pinto | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 May 2025 | 148,953 | 148,953 | - | - | Stock Option (Right to Buy) | |
| Metsera Inc | Joshua Pinto | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 May 2025 | 148,953 | 0 | - | - | Stock Option (Right to Buy) | |
| Metsera Inc | Joshua Pinto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 16,125 | 16,125 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale of securities on an exchange or to another person at price $ 1.67 per share. | 18 Feb 2025 | 8,048 | 76,952 | - | 1.7 | 13,477 | Common Stock |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 3,000,000 | 3,000,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 720,084 | 720,084 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 720,084 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 270,828 | 270,828 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 270,828 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 223,034 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 223,034 | 223,034 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 223,034 | 223,034 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 223,034 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 170,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 127,448 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 127,448 | 127,448 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.39 per share. | 27 Aug 2024 | 15,693 | 138,965 | - | 11.4 | 178,806 | Common Stock |
| Neumora Therapeutics Inc | Joshua Pinto | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 22 Aug 2024 | 31,642 | 154,658 | - | 11.8 | 372,588 | Common Stock |
| Neumora Therapeutics Inc | Joshua Pinto | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.63 per share. | 22 Aug 2024 | 28,496 | 210,469 | - | 11.6 | 331,468 | Common Stock |
| Neumora Therapeutics Inc | Joshua Pinto | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.59 per share. | 22 Aug 2024 | 24,169 | 186,300 | - | 11.6 | 280,005 | Common Stock |
| Neumora Therapeutics Inc | Joshua Pinto | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Apr 2024 | 238,965 | 238,965 | - | 0 | Common Stock | |
| Neumora Therapeutics Inc | Joshua Pinto | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 85,000 | 323,965 | - | 0 | Common Stock |